7:00-7:30 PM Registration and Dinner

7:30-7:40 Introduction, ARS Pre-Test
Bernard A. Cohen, MD, FAAP

7:40-7:55 Incidence, Prevalence, and Pathophysiology of Acne
Anthony J. Mancini, MD, FAAP

7:55-8:10 Importance of Early Diagnosis and Treatment of Acne
Adelaide Ann Hebert, MD

8:10-8:15 Audience Q&A

8:15-8:40 Practical Applications: Case Study Reviews
Bernard A. Cohen, MD, FAAP

• 3 common, yet challenging, patient cases
• Treatment-related questions posed to audience via ARS keypads
• Question & answer period will follow each case

8:40-8:45 ARS Post-Test
Bernard A. Cohen, MD, FAAP

8:45-9:00 Panel Discussion /Audience Q&A

Acne is the most common skin disorder in the United States as an estimated 80 percent of all people between the ages of 11 and 30 experience outbreaks. The pattern of disease, relative severity, distribution, and patient's social circumstances will influence appropriate management. However, effective management also includes patient education about acne, its natural history, and dispelling acne myths. Effective management of acne often requires using a combination of treatments that act on different aspects of the pathogenic process of acne development.

The program is designed to reinforce and supplement the pediatrician’s knowledge about the pathogenesis, recognition, and management of acne. Emphasis will be placed on highlighting available therapeutic options and the integral role pediatricians play in each component of management to further ensure positive clinical outcomes.

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

At the conclusion of this activity, participants should be able to:

• Recognize the prevalence and pathogenesis of acne to improve outcomes of treatment in the pediatric population
• Summarize the mechanisms of action and discuss the practical applications of the latest acne treatments
• Evaluate various treatment methods, with specific focus on pharmacologic agents to improve patient quality of life for those affected by acne
• Develop an individualized treatment plan depending on the patient’s age and severity of the patient’s condition

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Intended Audience
This activity is designed to meet the educational needs of pediatricians who are active in the diagnosis and management of acne. There are no prerequisites for attendees.

Americans with Disabilities Act
The Johns Hopkins University School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

Policy on Faculty and Provider Disclosure
It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the course handout materials.

Supported by an educational grant from Dermik Laboratories, a subsidiary of sanofi-aventis U.S.

Presented by the Johns Hopkins University School of Medicine.